Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 99,400 shares at $62.26 ($6.2M) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Open-market sale of $6.2M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.26 | 7,481 | $466K | 7.6% |
| 2 | $62.26 | 7,481 | $466K | 7.6% |
| 3 | $62.98 | 4,588 | $289K | 4.7% |
| 4 | $62.98 | 4,588 | $289K | 4.7% |
| 5 | $63.95 | 600 | $38K | 0.6% |
| 6 | $62.70 | 16,033 |
| $1.0M |
| 16.3% |
| 7 | $62.70 | 16,033 | $1.0M | 16.3% |
| 8 | $63.15 | 2,617 | $165K | 2.7% |
| 9 | $63.15 | 2,617 | $165K | 2.7% |
| 10 | $59.60 | 2,192 | $131K | 2.1% |
| 11 | $59.60 | 2,192 | $131K | 2.1% |
| 12 | $60.71 | 10,022 | $608K | 9.9% |
| 13 | $60.71 | 10,022 | $608K | 9.9% |
| 14 | $61.52 | 3,561 | $219K | 3.6% |
| 15 | $61.52 | 3,561 | $219K | 3.6% |
| 16 | $62.38 | 2,906 | $181K | 2.9% |
| 17 | $62.38 | 2,906 | $181K | 2.9% |
| Total | $62.05 avg | 99,400 | $6.2M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |